Post-Partum Depression Market Size Projected to Hit USD 14.7 Billion by 2035
According to the IMARC Group, the post-partum depression market size reached a value of USD 4.9 billion in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 14.7 billion by 2035, exhibiting a growth rate (CAGR) of 10.47% during 2025-2035. This can be attributed to the high adoption of combination therapies as well as the growing usage of selective serotonin reuptake inhibitors catering to their high level of effectiveness and general safety.
Post-partum depression is a kind of mood disorder that affects women after childbirth. The post-partum depression market is experiencing significant growth due to various interconnected factors. Primarily, the increasing prevalence of PPD and the growing awareness about mental health issues are driving the demand for effective treatments. Additionally, the market is positively supported by advancements in medical research that have led to the development of novel therapeutic options, including antidepressants and hormone-based therapies, which offer improved patient outcomes. Expanding healthcare infrastructure, particularly in emerging markets, enhances access to diagnostic and treatment facilities, further propelling post-partum depression market growth. Moreover, supportive government initiatives and increased funding for mental health programs are encouraging the development of innovative treatments.
Telemedicine and digital health platforms have also played a major role in extending entry to mental health care, allowing new mothers to seek help more conveniently and discreetly. Apart from this, strategic collaborations between pharmaceutical companies and research institutions are fostering the development of more targeted and effective therapies. Furthermore, the trend towards personalized medicine, which tailors treatment based on individual patient profiles, is anticipated to drive the post-partum depression market over the forecasted period. This approach promises more precise and effective treatment options, ultimately improving patient outcomes and contributing to market growth.
Request for a sample of this report: https://www.imarcgroup.com/post-partum-depression-market/requestsample
Countries Covered:
• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country:
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the post-partum depression market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the post-partum depression market
• Reimbursement scenario in the market
• In-market and pipeline drugs
This report also provides a detailed analysis of the current post-partum depression market drugs and late-stage pipeline drugs.
In-Market Drugs:
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs:
• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance
Competitive Landscape with key players:
The competitive landscape of the post-partum depression market has been studied in the report with the detailed profiles of the key players operating in the market.
Sage Therapeutics
GH Research
Brii Biosciences
Ask the Analyst for Customization and Explore the Full Report with TOC: https://www.imarcgroup.com/request?type=report&id=6687&flag=E
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
**About Us:
**
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
